Nearly half of 844 million chronic kidney disease cases remain undiagnosed worldwide: Lancet
A new series in The Lancet reveals that nearly half of the 844 million chronic kidney disease (CKD) cases worldwide remain undiagnosed, with rates potentially higher in low- and middle-income countries. Researchers advocate for wider use of simple urine tests for early diagnosis, as CKD often progresses silently and is projected to become the fifth leading cause of death globally by 2040.
Why it matters
This highlights a critical global health crisis, as early diagnosis of CKD through simple tests can significantly slow or prevent disease progression, reducing mortality and the burden on healthcare systems, especially in underserved regions.
An estimated 30% to 50% of chronic kidney disease (CKD) cases remain undiagnosed even in high-income countries, with the proportion likely to be much higher in low- and middle-income nations, according to a new series of papers published in The Lancet . Researchers have urged wider use of simple urine tests to improve early diagnosis and treatment of a disease that affects 844 million adults worldwide.
The article reports on a scientific study published in a reputable medical journal, presenting facts and expert recommendations without overt political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in